Government of Canada invests in three teams of Canadian and Latin American and Caribbean scientists to help address unanswered questions about Zika virus
OTTAWA, March 16, 2017 /CNW/ - The spread of the Zika virus, which can cause devastating birth defects, has become a pressing public health issue in many countries. To this day, there is no vaccine to prevent and no medicine to treat Zika virus infections.
The Honourable Jane Philpott, Canada's Minister of Health, announced a $3 million investment for Zika research in May 2016. The Canadian Institutes of Health Research (CIHR), in partnership with the International Development Research Centre, today announced the names of the three teams of Canadian scientists who will collaborate with Latin American and Caribbean researchers to study the Zika virus.
- Dr. Tom Hobman, from the University of Alberta, and his team will study how the Zika virus changes host cells during infection, with the goal of developing anti-viral therapies that can be used against the virus.
- Dr. Keith Pardee, from the University of Toronto, and his team will test a new, low-cost tool to rapidly detect the presence of Zika virus in patients' bodily fluids. The new diagnostic tool is designed to be used in remote, under-resourced locations and will be field tested in Ecuador, Brazil and Colombia. Current tests to diagnose Zika virus are time consuming and prone to false positives due to the possibility of a patient's prior infection with other flaviviruses such as dengue.
- Dr. Beate Sander, from Public Health Ontario, and her team will conduct field studies in Argentina, Colombia and Ecuador to better understand how the virus is spread from mosquitoes to humans, predict which areas in the region are most at risk and use computer simulations to assess the most effective intervention methods, including mosquito control measures and vaccine development.
Together, the international teams will create new knowledge to help develop diagnostics for Zika virus infection, understand the pathology caused by the virus, and ultimately prevent its transmission and morbidity.
Quote
"In collaboration with their counterparts in Latin America and the Caribbean, these Canadian scientists will help answer some of the many outstanding questions we have about the Zika virus, ultimately providing evidence that will inform public health policy and improve how governments respond to outbreaks of the virus."
- Jane Philpott
Minister of Health
"The health research community is only beginning to come to grips with this dangerous pathogen. These three research teams have the potential to shed new light on the Zika virus and save lives. They may come up with faster ways to test for infection, finding the best methods to stop the mosquitoes that spread the virus and develop therapies that are effective against Zika."
- Dr. Marc Ouellette
Scientific Director, CIHR Institute of Infection and Immunity
"This initiative is key to helping protect populations in the Americas and Canada from Zika and other related diseases. Zika is an insidious virus that exacts a severe burden on vulnerable groups in Latin America, particularly mothers, children and poor urban populations facing limited access to health services. This funding will allow leading researchers from Latin America and Canada to collaborate on cutting-edge research, discovering new knowledge and tools to more rapidly detect, respond and control the virus."
- Jean Lebel
President, International Development Research Centre
Quick Facts
- To date, there have been 481 cases of Zika virus detected in Canada, most of which have been travel related, although the virus can also be transmitted from mother to fetus and sexually transmitted. There are currently no cures for Zika virus infections or vaccines available against the virus.
- Zika is linked to severe birth defects, like microcephaly, and neurological disorders including Guillain-Barré syndrome, a rare condition in which the body's immune system attacks its nervous system.
- The Public Health Agency of Canada recommends that pregnant women and those planning a pregnancy avoid travel to countries or areas in the United States, like Florida, with reported mosquito-borne Zika virus.
At the Canadian Institutes of Health Research (CIHR) we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
About the International Development Research Centre
Part of Canada's foreign affairs and development efforts, IDRC invests in knowledge, innovation, and solutions to improve lives and livelihoods in the developing world. Bringing together the right partners around opportunities for impact, IDRC builds leaders for today and tomorrow and helps drive large-scale positive change.
Canada-Latin America-Caribbean Zika Virus Program Funding Announcement
Project Information
| Principal Investigator |
Project Title |
Funding Program |
CIHR Funding |
IDRC Funding |
| Canada: Dr. Beate Sander International: Dr. Camila González Rosas (Colombia) |
Assessing ZIKV transmission dynamics and mitigation strategies. A multidisciplinary approach. |
Team Grant: Canada-Latin/America-Caribbean Zika Virus Program - Diagnostics |
$499,866 |
$499,900 |
| Canada: Dr. Tom Hobman International: Dr. Ana M de Filippis (Brazil) |
Molecular basis for Zika virus pathogenesis. |
Team Grant: Canada-Latin/America-Caribbean Zika Virus Program - Diagnostics |
$499,953 |
$506,000 |
| Canada: Dr. Keith Pardee International: Dr. Varsovia Cevallos (Ecuador) Dr. Lindomar Pena (Brazil) Dr. Jaime Castellanos (Colombia) |
Development and Deployment of Low Cost, Paper-based Zika Diagnostics. |
Team Grant: Canada-Latin/America-Caribbean Zika Virus Program - Diagnostics |
$500,000 |
$515,000 |
SOURCE Canadian Institutes of Health Research
David Coulombe, Media Relations, Canadian Institutes of Health Research, 613-941-4563; Ghislain Desjardins, Public Affairs, International Development Research Centre, 613-696-2177
Share this article